Acurx Pharmaceuticals (ACXP) Short Interest Ratio & Short Volume → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free ACXP Stock Alerts $2.25 +0.16 (+7.66%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Acurx Pharmaceuticals Short Interest DataCurrent Short Volume615,500 sharesPrevious Short Volume579,100 sharesChange Vs. Previous Month+6.29%Dollar Volume Sold Short$1.38 millionShort Interest Ratio / Days to Cover7.4Last Record DateApril 30, 2024Outstanding Shares15,760,000 sharesFloat Size13,190,000 sharesShort Percent of Float4.67%Today's Trading Volume170,421 sharesAverage Trading Volume140,986 sharesToday's Volume Vs. Average121% Short Selling Acurx Pharmaceuticals ? Sign up to receive the latest short interest report for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatACXP Short Interest Over TimeACXP Days to Cover Over TimeACXP Percentage of Float Shorted Over Time Ad Banyan Hill PublishingLook Who Fired the World’s Richest ManThis company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. Acurx Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024615,500 shares $1.38 million +6.3%4.7%7.4 $2.25 4/15/2024579,100 shares $946,828.50 +71.6%4.8%5.6 $1.64 3/31/2024337,400 shares $826,630.00 +14.6%2.8%2 $2.45 3/15/2024294,500 shares $801,040.00 +0.9%2.5%1.7 $2.72 2/29/2024291,900 shares $837,753.00 -3.2%2.6%1.3 $2.87 2/15/2024301,500 shares $919,575.00 -12.3%2.7%1.3 $3.05 Get the Latest News and Ratings for ACXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024343,700 shares $1.12 million +41.1%3.0%1.4 $3.27 1/15/2024243,600 shares $1.13 million -18.5%2.1%0.7 $4.63 12/31/2023298,800 shares $1.14 million -32.0%2.6%0.5 $3.83 12/15/2023439,100 shares $1.54 million -21.0%3.9%0.5 $3.50 11/30/2023555,800 shares $1.96 million -14.3%5.0%0.7 $3.52 11/15/2023648,300 shares $2.23 million -31.5%5.8%0.9 $3.44 10/31/2023946,100 shares $5.06 million -9.0%9.0%1.3 $5.35 10/15/20231,040,000 shares $4.51 million +10,197.0%9.9%1.6 $4.34 9/30/202310,100 shares $15,150.00 +50.8%0.1%0 $1.50 9/15/20236,700 shares $11,859.00 -51.1%0.1%0.2 $1.77 8/31/202313,700 shares $26,441.00 +95.7%0.1%0.4 $1.93 8/15/20237,000 shares $11,200.00 -63.0%0.1%0.2 $1.60 7/31/202318,900 shares $38,367.00 +42.1%0.2%0.7 $2.03 7/15/202313,300 shares $28,462.00 +58.3%0.1%0.5 $2.14 6/30/20238,400 shares $22,260.00 -27.6%0.1%0.3 $2.65 6/15/202311,600 shares $31,900.00 +39.8%0.1%0.5 $2.75 5/31/20238,300 shares $25,730.00 -60.9%0.1%0.3 $3.10 5/15/202321,200 shares $71,868.00 -7.0%0.2%0.7 $3.39 4/30/202322,800 shares $68,172.00 +4.1%0.3%0.7 $2.99 4/15/202321,900 shares $64,824.00 -25.5%0.2%0.7 $2.96 3/31/202329,400 shares $101,724.00 -52.8%0.3%0.9 $3.46 3/15/202362,300 shares $212,443.00 +150.2%0.7%1.8 $3.41 2/28/202324,900 shares $82,419.00 -33.8%0.3%0.7 $3.31 2/15/202337,600 shares $131,976.00 +78.2%0.4%1.2 $3.51 1/31/202321,100 shares $75,960.00 -7.9%0.2%0.7 $3.60 1/15/202322,900 shares $97,325.00 -3.4%0.2%0.9 $4.25 12/30/202223,700 shares $94,326.00 -18.0%0.3%1 $3.98 12/15/202228,900 shares $112,710.00 +26.8%0.3%1.4 $3.90 11/30/202222,800 shares $72,732.00 -1.3%0.2%1 $3.19 11/15/202223,100 shares $72,072.00 +5.5%0.3%1 $3.12 10/31/202221,900 shares $67,452.00 -27.2%0.2%0.8 $3.08 10/15/202230,100 shares $88,795.00 -22.2%0.3%1.1 $2.95 9/30/202238,700 shares $116,100.00 +45.5%0.4%1.5 $3.00 9/15/202226,600 shares $103,740.00 +10.8%0.3%1 $3.90Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company ACXP Short Interest - Frequently Asked Questions What is Acurx Pharmaceuticals' current short interest? Short interest is the volume of Acurx Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 615,500 shares of ACXP short. 4.67% of Acurx Pharmaceuticals' shares are currently sold short. Learn More on Acurx Pharmaceuticals' current short interest. What is a good short interest ratio for Acurx Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACXP shares currently have a short interest ratio of 7.0. Learn More on Acurx Pharmaceuticals's short interest ratio. Which institutional investors are shorting Acurx Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Acurx Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Acurx Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.67% of Acurx Pharmaceuticals' floating shares are currently sold short. Is Acurx Pharmaceuticals' short interest increasing or decreasing? Acurx Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 615,500 shares, an increase of 6.3% from the previous total of 579,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acurx Pharmaceuticals' float size? Acurx Pharmaceuticals currently has issued a total of 15,760,000 shares. Some of Acurx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acurx Pharmaceuticals currently has a public float of 13,190,000 shares. How does Acurx Pharmaceuticals' short interest compare to its competitors? 4.67% of Acurx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acurx Pharmaceuticals: NRx Pharmaceuticals, Inc. (6.36%), BriaCell Therapeutics Corp. (4.76%), Fortress Biotech, Inc. (12.69%), Aprea Therapeutics, Inc. (1.90%), Spruce Biosciences, Inc. (0.97%), Apollomics, Inc. (0.19%), Daré Bioscience, Inc. (0.29%), ImmunoPrecise Antibodies Ltd. (1.45%), Viracta Therapeutics, Inc. (2.54%), Theratechnologies Inc. (0.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Acurx Pharmaceuticals stock? Short selling ACXP is an investing strategy that aims to generate trading profit from Acurx Pharmaceuticals as its price is falling. ACXP shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acurx Pharmaceuticals? A short squeeze for Acurx Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACXP, which in turn drives the price of the stock up even further. How often is Acurx Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACXP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NRx Pharmaceuticals Short Interest BriaCell Therapeutics Short Interest Fortress Biotech Short Interest Aprea Therapeutics Short Interest Spruce Biosciences Short Interest Apollomics Short Interest Daré Bioscience Short Interest ImmunoPrecise Antibodies Short Interest Viracta Therapeutics Short Interest Theratechnologies Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACXP) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News